IceCure Receives FDA Clearance for Expanded Indications of Cryoablation Technology and Regulatory Approval of New MultiSense System; Plans to Increase U.S. Presence and Operations
Expands Use of Cryoablation Technology to Treat Liver and Kidney Tumors. Read more here
This website stores cookies on your computer, and employs other similar means to automatically collect data. These means are used to improve your website experience and to enable us to better administer the website and its content. Please read our Cookies Policy for additional information.
